Riskpilot← Back to searchSign inGet full accessSEAGULL ApS
APSActiveCVR 29387958Industrivej 1Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20067 employeesseagull-healthcare.dk
Revenue 2025
DKK 3,8M
+18% vs 2024
EBITDA margin
2.9%
-72% vs 2024
Equity ratio
18.4%
Financial strength
Net profit 2025
DKK 37K
-84% vs 2024
| Revenue | DKK 3,8M | +18% |
| EBITDA | DKK 111K | -72% |
| Net profit | DKK 37K | -84% |
| Total assets | DKK 6M | +22% |
| Equity | DKK 1,1M | -5% |
| Employees | 7 | — |
Legal name
SEAGULL ApS
CVR number
29387958
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2. februar 2006
Share capital
DKK 126.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er at drive virksomhed med medicinaludstyr og anden aktivitet efter direktionens anvisning.
Address
Industrivej 1
Phone
+4561715035
Email
anni@seagull-healthcare.dk
Website
seagull-healthcare.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2.575 | 2.593 | 2.804 | 3.259 | 3.842 |
| Staff expenses | -2.414 | -2.472 | -2.472 | -2.858 | -3.731 |
| EBITDA | 161 | 121 | 332 | 402 | 111 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 161 | 121 | 332 | 402 | 111 |
| Net financials | -72 | -114 | -128 | -102 | -61 |
| Profit before tax | 90 | 7 | 204 | 299 | 50 |
| Tax | 20 | 2 | 46 | 67 | 12 |
| Net profit | 69 | 5 | 159 | 233 | 37 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4.347 | 4.862 | 4.801 | 4.905 | 5.968 |
| Equity | 761 | 767 | 925 | 1.158 | 1.096 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3.580 | 4.087 | 3.860 | 3.735 | 4.849 |
| Total debt | 3.580 | 4.087 | 3.860 | 3.735 | 4.849 |
EBITDA margin
2.9%
This company
15.8%
Market median
-82% vs market
20212025
Equity ratio
18.4%
This company
38.2%
Market median
-52% vs market
20212025
Return on equity
3.4%
This company
18.4%
Market median
-82% vs market
20212025
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
20212025
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20212025
Debt / equity
4.45×
This company
0.62×
Market median
-618% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AP Management | Management | 2006 |
| Former (1) | ||
NB Management | Management | 2006 – 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LUH ApS
SEAGULL ApS Board members of SEAGULL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nicolai Bille Krogh | Management | 0 companies |
| Anni Pia Tolstrup-Christensen | Management | 0 companies |
| Annemette Vestergaard Thomsen | Board of Directors | 0 companies |
| Agnes Friese Skov | Chairman | 0 companies |